LISTEN LIVE: Loading...
LISTEN LIVE: Loading...

Advertisement

 

FDA-Approved Knock-Offs Of Biotech Drugs Could Safely Save Big Bucks

In 2015, the Sandoz unit of drugmaker Novartis won Food and Drug Administration approval of a drug called Zarxio, which is similar to Amgen's Neupogen, a medicine that boosts the production of white blood cells. (Sebastien Bozon/AFP/Getty Images)
In 2015, the Sandoz unit of drugmaker Novartis won Food and Drug Administration approval of a drug called Zarxio, which is similar to Amgen's Neupogen, a medicine that boosts the production of white blood cells. (Sebastien Bozon/AFP/Getty Images)

Related:

Advertisement

 
Play
Listen Live
/00:00
Close